Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alternative Chemotherapies for Lymphatic Filariasis
NCT02974049Completed
- Sponsor
- University Hospitals Cleveland Medical Center
- Start
- Jan 2015
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of albendazole in lymphatic filariasis (LF) (4 arms), sponsored by University Hospitals Cleveland Medical Center. Primary endpoint: Total clearance of Microfilariae at 36 months. Started Jan 2015; status: completed.
02
Drugs
albendazole
03
Conditions
lymphatic filariasis (LF)
Beyond the preview
Go deeper on NCT02974049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02974049.